Concepedia

Hiromi Wada

HW

193

Publications

10.1K

Citations

50

H-Index

1981

Active since

Affiliations

Kyoto University(Current)

Kyoto University Hospital

Taiho Pharmaceutical (Japan)

Kyoto Prefectural University of Medicine

Hiromi Wada is an author at Kyoto University specializing in medicine, lung cancer, and oncology.

ORCID

Top concepts

Publications per year

1981–2022

193

Publications

193

A Randomized Trial of Adjuvant Chemotherapy with Uracil–Tegafur for Adenocarcinoma of the Lung

Harubumi Kato, Yukito Ichinose, Morio Ohta et al. · New England Journal of Medicine · 2004 · 828 citations · Full text

Constitutive activation of the 41-/43-kDa mitogen-activated protein kinase signaling pathway in human tumors

Rika Hoshino, Yuji Chatani, Takao Yamori et al. · Oncogene · 1999 · 689 citations · Full text

, , +12

Adjuvant chemotherapy after complete resection in non-small-cell lung cancer. West Japan Study Group for Lung Cancer Surgery.

Hiromi Wada, Shigeki Hitomï, T Teramatsu · Journal of Clinical Oncology · 1996 · 290 citations

Evaluation of angiogenesis in non-small cell lung cancer: comparison between anti-CD34 antibody and anti-CD105 antibody.

Fumihiro Tanaka, Yosuke Otake, Kazuhiro Yanagihara et al. · PubMed · 2001 · 274 citations

Thirty-day operative mortality for thoracotomy in lung cancer

Hiromi Wada, Takayuki Nakamura, Kenbu Nakamoto et al. · Journal of Thoracic and Cardiovascular Surgery · 1998 · 243 citations · Full text

, , +3

Rows per page

1–5 of 193